This content is machine translated Thyroid Cancer System therapy: Current developments Targeted systemic therapies have become increasingly important in both anaplastic and advanced radioiodine-refractory differentiated thyroid carcinoma. These have proven to be effective options over the past several years in the…
View Post 3 min This content is machine translated Non-small cell lung cancer Platelets to predict immunotherapy response? Immunotherapy using checkpoint inhibitors has become an indispensable part of the treatment of non-small cell lung cancer. Nevertheless, there is room for improvement – and potential – in the area…
View Post 5 min This content is machine translated Diffuse large B-cell lymphoma (DLBCL) Innovative Salvage Therapy for Advanced DLBCL Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. If left untreated, accumulations of lymphoma cells impede the function of affected organs and lead to the death…
View Post 3 min This content is machine translated Non-small cell lung cancer Who benefits from targeted therapy? A large multicenter study led by the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim confirms substantial differences in treatment response and provides important insights for treatment planning.
View Post 2 min This content is machine translated Cancer Therapy Only individualized nutrition therapy helps prevent malnutrition Low-germ diets in the treatment of cancer patients are associated with significant risks from a scientific perspective and should no longer be practiced.
View Post 9 min This content is machine translated Locally advanced/metastatic breast carcinoma 44th San Antonio Breast Cancer Symposium: Best Of From December 7-10, 2021, the 44th San Antonio Breast Cancer Symposium took place in a physical-virtual hybrid event. In a series of exciting lectures, the latest clinical and preclinical findings…
View Post 6 min This content is machine translated Gliomas New indications for immuno-oncology? While immunotherapies are rapidly gaining ground in other entities, they are still in their infancy in CNS tumors. This is due in part to the often low immunogenicity. Nevertheless, antibody-based therapies,…
View Post 10 min This content is machine translated Iron overload Pathophysiology and clinic Iron overload is an unavoidable and potentially life-threatening consequence of multiple red cell concentrate transfusions. Because the clinical manifestations are nonspecific and usually develop slowly, this complication is often overlooked. CME-Test
View Post 20 min This content is machine translated Head and Neck Tumors New therapies Tumors of the head and neck were the seventh most common cancer worldwide in 2018. The most important risk factors include nicotine and alcohol consumption. The prognosis and multimodality treatment… CME-Test
View Post 3 min This content is machine translated HRD-positive advanced ovarian cancer. PARP inhibitor recommended for first-line maintenance therapy Poly-ADP-ribose polymerase (PARP) inhibitors have added valuable options to the therapeutic landscape in advanced ovarian cancer and have already found their way into ASCO and NCCN guidelines [1–3]. With the…
View Post 12 min This content is machine translated Malignant melanoma Adjuvant Therapy: State of the Art The annual incidence of malignant melanoma has steadily increased over the past 40 years. While the prognosis is good in the early stages, it worsens as the tumor stage increases.… CME-Test
